# Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

> **NCT00707993** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 441 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin
- **DRUG:** Glipizide

## Key facts

- **NCT ID:** NCT00707993
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 441 (ACTUAL)
- **Last updated:** 2013-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707993, "Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00707993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*